Uncompliant Product Name Leads To Warning Letter
Citing ingredient research is a marketing claim
![Uncompliant Product Name Leads To Warning Letter](https://static.wixstatic.com/media/98d61c_7a4da9304b584010a9abd836f8f5a2d8~mv2.jpg/v1/fill/w_418,h_350,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/WLW%2003-02-22%20Ingredient%20benefits%20on%20commercial%20website.jpg)
#WarningLetterWednesday
This company received a warning letter for claims made in a product name. The product “Covid-19 Immune Support” is a bold Covid prevention and treatment claim. This is a basic but important reminder that product names are marketing claims.
The company was also cited for referencing Covid studies for an ingredient in their products. This “implied claim” enforcement is a continuing trend, and I caution companies to remove ingredient study references that contain disease words from their website. I talk more about this here.
This is a joint FDA and FTC warning letter and includes a cease and desist demand. I talk more about what this means here.
Read the full warning letter here.
Disclaimer: The educational information provided here is for informational purposes only. Contact an attorney for specific legal advice. Rule #1 in compliance is to ensure marketing is truthful and not misleading.